Overall, our findings demonstrate that TDP-43 worsens p-tau pathology, which is then reflected in higher burdens and increased seeding potential of p-tau in the brains of AD(LATE-NC+) patients. The gene discussed is MAPT; the disease is Alzheimer disease.